Filing Details
- Accession Number:
- 0001127602-13-012430
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-04-01 12:51:01
- Reporting Period:
- 2013-03-28
- Filing Date:
- 2013-04-01
- Accepted Time:
- 2013-04-01 11:51:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
711404 | Cooper Companies Inc | COO | Ophthalmic Goods (3851) | 942657368 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1368867 | G Daniel Mcbride | The Cooper Companies, Inc. 6140 Stoneridge Mall Road, Suite 590 Pleasanton CA 94588 | Vp, General Counsel & Cro | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-03-28 | 15,000 | $13.21 | 28,944 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-03-28 | 15,000 | $107.50 | 13,944 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-03-28 | 6,000 | $13.10 | 19,944 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-03-28 | 6,000 | $107.50 | 13,944 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2013-03-28 | 15,000 | $0.00 | 15,000 | $13.21 |
Common Stock | Stock Options (Right to Buy) | Disposition | 2013-03-28 | 6,000 | $0.00 | 6,000 | $13.10 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2018-12-09 | No | 4 | M | Direct | |
6,000 | 2018-12-10 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 2,120 | Indirect | 401(k) Plan |
Footnotes
- Sale price represents an average of the selling prices between $107.24 and 107.77.
- 12/10/08 NQ Grant: The options will vest in equal increments over four years measured from the date of grant as follows: 1/4 shall vest on 12/10/09; 1/4 shall vest on 12/10/10; 1/4 shall vest on 12/10/11; and 1/4 shall vest on 12/10/12.
- 12/11/08 NQ Grant: The options will vest in equal increments over five years measured from the date of grant as follows: 1/5 shall vest on 12/11/09; 1/5 shall vest on 12/11/10/; 1/5 shall vest on 12/11/11; 1/5 shall vest on 12/11/12; and 1/5 shall vest on 12/11/13.